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Abstract
Background: An overload of health-related information is available for patients on numerous websites, guidelines, and
information leaflets. However, the increasing need for personalized health-related information is currently unmet.
Objective: This study evaluates an educational e-tool for patients with non-Hodgkin’s lymphoma (NHL) designed to meet
patient needs with respect to personalized and complete health-related information provision. The e-tool aims to help NHL patients
manage and understand their personal care pathway, by providing them with insight into their own care pathway, the possibility
to keep a diary, and structured health-related information.
Methods: Together with a multidisciplinary NHL expert panel, we developed an e-tool consisting of two sections: (1) a personal
section for patients’ own care pathway and their experiences, and (2) an informative section including information on NHL. We
developed an ideal NHL care pathway based on the available (inter)national guidelines. The ideal care pathway, including date
of first consultation, diagnosis, and therapy start, was used to set up the personal care pathway. The informative section was
developed in collaboration with the patient association, Hematon. Regarding participants, 14 patients and 6 laymen were asked
to evaluate the e-tool. The 24-item questionnaire used discussed issues concerning layout (6 questions), user convenience (3
questions), menu clarity (3 questions), information clarity (5 questions), and general impression (7 questions). In addition, the
panel members were asked to give their feedback by email.
Results: A comprehensive overview of diagnostics, treatments, and aftercare can be established by patients completing the
questions from the personal section. The informative section consisted of NHL information regarding NHL in general, diagnostics,
therapy, aftercare, and waiting times. Regarding participants, 6 patients and 6 laymen completed the questionnaire. Overall, the
feedback was positive, with at least 75% satisfaction on each feedback item. Important strengths mentioned were the use of a
low health-literacy level, the opportunity to document the personal care pathway and experiences, and the clear overview of the
information provided. The added value of the e-tool in general was pointed out as very useful for preparing the consultation with
one’s doctor and for providing all information on one website, including the opportunity for a personalized care pathway and
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diary. The majority of the revisions concerned wording and clarity. In addition, more explicit information on immunotherapy,
experimental therapy, and psychosocial support was added.
Conclusions: We have developed a personal care management e-tool for NHL patients. This tool contains a unique way to help
patients manage their personal care pathway and give them insight into their NHL by providing health-related information and
a personal diary. This evaluation showed that our e-tool meets patients’needs concerning personalized health-related information,
which might serve as a good example for other oncologic diseases. Future research should focus on the possible impact of the
e-tool on doctor-patient communication during consultations.
(JMIR Res Protoc 2015;4(1):e6)   doi:10.2196/resprot.3407
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Introduction
Overview
In the current digital era, patients are overloaded with
health-related information. Many patient associations, health
care institutes, hospitals, scientific societies, and guideline
working groups provide their own information through websites
and flyers. Unfortunately, the increasing call for personalized
health-related information is still unmet [1-3]. On the one hand,
this information need includes tools that provide support during
interaction with caregivers, such as question sheets, decision
aids, and option grids [4-6]. These tools aim at providing
information about available (treatment) options and possible
risks to make a well-informed decision. Decision aids, for
example, are shown to be effective with regard to improvement
of patients’ involvement and health-related knowledge [7].
On the other hand, patients ask for more insight into their
personal care pathway, including diagnostics, therapy, and
aftercare [8], which makes it easier to act as managers of their
own care. This also points to personalized care, which can be
defined as the delivery of care that is tailored to an individual
patient. Important elements are (1) the delivery of care that is
responsive to individual preferences, needs, values, and
possibilities, and (2) as much as possible, patients’ engagement
in their own care and health. The latter point needs a
well-informed patient, who has insight into his personal care
pathway. In the literature, roadmaps or care pathways
concerning patient care are mostly directed to professionals
[9,10]. However, making these available for patients could help
them in their personal care management.
In addition, reliable health-related information is particularly
important for patients, where the Internet is an information
source of growing importance. A national survey in the United
States showed that 59% of adults searched online for
health-related information in 2012 [11]. In European countries,
over 80% of adults used the Internet as the main source for
health-related information in 2011 and 2012 [12,13]. Several
quality criteria have been developed worldwide to monitor the
quality of easily accessible health-related information on the
Internet [14]. The best-known quality criteria are found in the
Health On the Net Code of Conduct (HONcode) for websites
[15]. Previous research showed that it remains difficult to
accurately monitor all information posted on the Internet, for
example, online information concerning cancer and other
disease-related topics is still of poor quality [16-21].
For non-Hodgkin’s lymphoma (NHL), a heterogeneous group
of over 40 types of malignant lymphomas, an abundance of
health-related information is available online. Previous research
showed that patients diagnosed with NHL would like to have
access to more complete and personalized information on
diagnostics, therapy, and aftercare [2]. In response to this, we
developed a unique e-tool for NHL patients. This study is, to
our knowledge, the first description on the development and
evaluation of a personalized care pathway for NHL patients that
is also linked to the available health-related information
concerning NHL.
Aim and Objectives
This paper describes the development and evaluation of a
unique, educational e-tool for NHL patients, aiming to help
patients manage and understand their personal NHL care
pathway. This is done by providing insight into their personal
care pathway based on the data patients enter and by providing
essential information about NHL care. Additionally, patients
are given the possibility to register personal experiences in their
care pathway, as they would in a diary. We hypothesize that
having access to all the information available in the e-tool,
patients will have a better understanding of their disease and
will be able to act as managers of their own care pathways
during interaction with their caregivers.
Methods
Setting
The e-tool described in this paper was developed in the context
of the PEARL study (improvement of patients’ hospital care
for non-Hodgkin’s lymphoma), aimed at improving hospital
care for patients diagnosed with NHL [22]. In a previous study,
insight into current NHL care was acquired by measuring quality
indicators at the patient level [23]. Together with the barriers
and facilitators found, as perceived by patients and physicians
[2], a tailored improvement strategy was developed. Next to
several physician-directed tools, an e-tool for patients was
included in the improvement strategy. This paper describes the
development and evaluation of an e-tool for NHL patients.
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E-Tool Development
Overview
We started with the development of a mock-up storyboard, and
with the help of a system developer this was converted into a
distinctive e-tool for NHL patients, tailored to address the
patients’ barriers found in previous research [2]. The barriers
included lack of insight into the patients’personal care pathway,
and lack of written information about diagnostics and therapy.
This is why the e-tool developed consists of two sections: (1)
a personal section for patients’ own NHL care pathway
(roadmap) and their experiences with NHL care, and (2) an
informative section including information on NHL. The
complete e-tool aims to help patients manage the care they
receive during their NHL care trajectory. The webmaster of the
Dutch Lymphoma Patient Association (Hematon, known as
LVN before 2014) and an expert panel, including a hematologist,
radiologist, pathologist, radiation oncologist, epidemiologist,
and a senior researcher, were closely involved in the e-tool
development. Quality criteria from the HONcode were taken
into account during the development process.
Personal Section of the E-Tool
In this section, users were able to document dates and
experiences of first consultation, diagnostics, and therapy. The
aim was to provide insight into the patients’ personal care
pathway. We developed a general (ideal) NHL care pathway
based on the national guidelines and recommendations available
in the Netherlands. These included, among others, the Dutch
NHL guidelines, recommendations of the Cooperative Trial
Group for Hematology Oncology (HOVON) and the Dutch
Society of Hematology (NVvH), general recommendations for
acceptable waiting times, and an NHL guideline based on
patients’ perspectives of Hematon. Internationally available
guidelines were consulted when applicable. The ideal care
pathway, including date of first consultation, date of diagnosis,
and start date of therapy, was used to set up the format for the
personal care pathway (roadmap).
Informative Section of the E-Tool
Users had access to reliable information on NHL and NHL care
through this section of the e-tool. The aim was to cluster all
reliable, online available information and make it understandable
for all users. Too much or confusing information and a high
health-literacy level were avoided as much as possible. The
Dutch NHL guidelines, NVvH, HOVON, the Dutch Cancer
Society (KWF), and several NHL-related websites (eg,
Radiotherapie Nederland, Chemo and nu, Hematon, and
Hematologie Groningen) were used as sources of NHL
information for the content. These sources are frequently
recommended and used by professionals, so the content can be
considered as authorized by them. We cooperated with the
webmaster of Hematon to make sure that the information
included was complete and accurate. The format of the e-tool
was based on the NHL care pathway as described in the
guidelines and on user experiences with other websites.
E-Tool Evaluation
After evaluation of the concept of the text by the expert panel,
an external hematologist, and the webmaster of Hematon, an
assessment was set up to evaluate both sections of our e-tool
concerning applicability. We recruited NHL patients via
Hematon and a university hospital in the Netherlands. Patients
were eligible when they had, or have had, a non-Hodgkin’s
lymphoma, were over 18 years old, and had access to the
Internet. Family and friends of 3 members of the project team
were asked to participate as laymen. The e-tool was evaluated
by patients and laymen using a 24-item questionnaire—19
yes/no questions, including space for reasoning, and 5
open-ended questions, including improvement suggestions. The
questionnaire included questions on layout (6 questions), user
convenience (3 questions), menu clarity (3 questions),
information clarity (5 questions), and general impression (7
questions), for example, strengths and missing information.
This method allowed us to obtain as much information as
possible to improve our e-tool. The expert panel was invited by
email to give general feedback on the e-tool.
Results
E-Tool Development
Overview
We developed an e-tool, consisting of two sections—a personal
section and an informative section. The content of the sections
will be described below, followed by the results of the evaluation
of the e-tool applicability. The e-tool is available in Dutch [24]
for participants of the PEARL study and will become publicly
available in 2015. The e-tool started with a general introduction,
which described the aim of the e-tool and gave a short overview
of the personal and informative sections of the e-tool. Both
sections were formatted in chronological order (diagnostics,
therapy, aftercare), which is in line with the NHL care pathway
as described in the guidelines and seen in clinical practice.
Additionally, background information was available concerning
the PEARL study, participating hospitals, and contact
information.
Personal Section of the E-Tool
This section consisted of questions concerning a patient’s
personal NHL care pathway, which allowed patients to develop
a unique overview of all diagnostics, treatments, and
aftercare/follow-up that they have had. Questions were divided
into four items:
1. Diagnostic examinations, including items such as type and
date of the examination, executed by whom, and in which
hospital.
2. Diagnosis, including date of first consultation, date of
diagnosis, type of NHL, stage of the disease, risk profile, date
of treatment plan, hospital name, and physician name.
3. Therapy, including type and date of therapy, executed by
whom, and in which hospital.
4. Aftercare, including items such as type and date of aftercare,
executed by whom, and contact information.
An easy link from the personal section to the informative section
was provided next to each item. In this way, patients could look
up the underlying information belonging to the different items.
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Additionally, it was possible to create a diary, to document their
own experiences with the different diagnostic examinations or
treatments. Information filled out in this diary was only visible
to the patients themselves. Finally, an overview of the personal
NHL care pathway was obtained using the answers to the
questions. The personal diary—chronologically visualized
experiences with NHL care—was provided when applicable.
An example of the personal NHL care pathway (roadmap) is
shown in Figure 1.
Figure 1. Example of a personal NHL care pathway (personal section of the e-tool). Original is in Dutch.
Informative Section of the E-Tool
This section consisted of NHL information from reliable online
sources, divided into six information items:
1. NHL in general, including a description of what NHL is,
symptoms, and most occurring NHLs.
2. Diagnostic examinations, including items such as blood
sample, tissue biopsy, bone marrow biopsy/aspirate,
PET/CT-scan, and additional examinations.
3. Diagnosis, including stage, international prognostic index
(IPI) score, treatment plan, and additional support.
4. Therapy, including wait-and-see, radiotherapy, chemotherapy,
immune therapy, stem cell transplantation, and clinical trials.
5. Aftercare, including response evaluation and monitoring.
6. Waiting times.
External links for more extensive information were added as
much as possible, together with short educational movies created
by KWF or Hematon. An example of the informative section
is shown in Figure 2.
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Figure 2. Example of informative section of the e-tool. Original is in Dutch.
E-Tool Evaluation
We asked 20 people to participate in our test, including 14 NHL
patients and 6 laymen. In total, 13 people logged in and 12
returned the questionnaire, which resulted in a 60% (12/20)
response rate. Little feedback was given by 1 participant by
email and he did not return the questionnaire. The mean age of
the 12 participants (patients and laymen) that completed the
questionnaire was 56 years (SD 11), with a range of 30-70 years.
Of the participants, 42% (5/12) were female and 67% (8/12)
had a high education level (college or university). Additionally,
all 6 panel members and the external hematologist provided
general feedback by email.
Table 1 includes the results of our e-tool evaluation
(applicability) using closed questions among NHL patients and
laymen. Overall, the evaluation of the e-tool was highly positive.
Table 1 shows at least 75% (9/12) satisfaction on each section.
Concerning layout, all responders were satisfied with the clarity
of the text, writing style, and clarity of the illustrations and short
videos. When looking at the user convenience, 11 out of 12
participants (92%) were satisfied with the format and speed of
the e-tool. In relation to menu clarity, all participants found the
menu format intuitive and the information needed was easy to
find. Information clarity, including understandability of the text,
was evaluated positively as well. Only 2 out of 12 participants
(17%) thought too much medical terminology was included.
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Table 1. Results of the e-tool evaluation among NHL patients and laymen (closed questions).
Positive response, n (%)Question
Laymen (n=6)Patients (n=6)
Layout
6 (100)6 (100)Is the text clear?
6 (100)3 (50)Are you satisfied with letter type and size?
6 (100)6 (100)Are you satisfied with the writing style?
5 (83)4 (67)Is the use of colors attractive to you?
5 (83)5 (83)Are there enough illustrations and short videos to support the text?
6 (100)6 (100)Are the illustrations and short videos clear?
User convenience
5 (83)4 (67)Is the e-tool easy to use?
6 (100)5 (83)Is the format of the e-tool easy to understand?
6 (100)6 (100)Are you satisfied with the speed of the e-tool?
Menu clarity
6 (100)6 (100)Does the composition of the menu seem natural?
5 (83)5 (83)Are you satisfied with the navigation through the e-tool?
6 (100)6 (100)Is it easy to find the information you are looking for?
Information clarity
6 (100)6 (100)Is the information provided on the e-tool understandable?
6 (100)4 (67)Does the e-tool make use of too much medical terminology?a
6 (100)6 (100)Do you understand what NHL is, after reading the information provided on the e-tool?
6 (100)6 (100)Do you understand what treatment options are available, after reading the e-tool?
General impression
5 (83)5 (83)Are there any flaws/errors in this e-tool?a
6 (100)5 (83)Would you use this e-tool if made available to you?
6 (100)6 (100)Are there any redundant items in this e-tool?a
aPercentage of negative responses presented, caused by negative questioning.
Table 2 includes the results of our e-tool evaluation using
open-ended questions, and shows mainly positive remarks about
the e-tool and some improvement points, according to NHL
patients and laymen. Valuable strengths mentioned by the
participants included the use of a low health-literacy level, the
opportunity to document their personal care pathways and
experiences (diary), and the clear and helpful overview of the
information provided. The added value of the e-tool in general
was pointed out as very useful for preparing for their
consultations with their doctors and for providing all information
in one website, including the opportunity for a personalized
care pathway and diary.
In general, the e-tool is considered to be a good initiative to
help patients manage their NHL care. For example, one
participant wrote, “I think this tool is excellent and that it will
be helpful in dealing with the fact that you are diagnosed with
NHL. The tool can contribute to an optimal doctor-patient
contact.” There were no distinct differences in feedback between
patients and laymen, except that patients provided more
comments concerning missing items and general remarks.
Improvement points proposed by the expert panel included
addition of a search function and contact button, adding items
to the personal care pathway section, suggestions for links to
general cancer websites, and some wording issues (data not
shown).
During the review of the e-tool, all feedback was taken into
account. The majority of the revisions concerned wording and
clarity. With respect to layout, the font size regarding
explanatory text was enlarged and the color of the submenu was
made less bright. Regarding user convenience and menu clarity,
the navigation at the bottom of each page was made clearer. No
revisions were made concerning information clarity. In addition,
more explicit information was included about immune therapy,
experimental therapy, and psychosocial support. As well, items
for the patients’ risk profiles and stages of disease were added
to the personal section.
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Table 2. Results of the e-tool evaluation among NHL patients and laymen (open-ended questions).
ResponseQuestion
Information clarity
Makes everything much clearer and understandable.
Makes it possible to read everything at a quiet moment.
Provides good preparation for consultation with your doctor.
Provides a great overview of all necessary information.
Provides a good overview of your own care pathway.
The e-tool is very useful for the patients’ relatives.
Makes it possible to compare with the ideal pathway.
What does this e-tool add to the information provid-
ed by your doctor?
General impression
More expressive color use.
For patients that forget updating their care pathway, are there alerts?
Better navigation through the care pathway.
Clearer definition of first consult.
What are improvement points for this e-tool?
Opportunity to document your personal care pathway.
Opportunity to document your experiences in a diary.
Possible to compare with quality criteria (ideal pathway).
Low health-literacy level.
Clear and calm colors.
Clear overview of medical information and terminology.
Clear layout and navigation.
External links to additional information about NHL.
Overview of information gives the opportunity to translate this to yourself.
What are the strengths of this e-tool?
Overview of lymph vessels.
Information about immune therapy and clinical trials.
Information about psychosocial support.
Information about second opinion.
What did you miss on this e-tool?
Great overview of available NHL information.
Other websites are fine, but this e-tool provides more specific information.
I already have my own diary, which I will use in the future.
The tool gives the opportunity to create your own care pathway and diary—this has a positive
influence on dealing with the fact that you are diagnosed with NHL.
This e-tool can contribute to an optimal doctor-patient contact during consultations.
General remarks?
Discussion
Principal Results
In this study, we showed the development and evaluation of a
unique e-tool for, and by, patients with non-Hodgkin’s
lymphoma. Based on the evaluation, the e-tool is a feasible tool
that gives patients insight into their personal care pathway and
informs them about NHL. The overall positive feedback implies
the e-tool’s added value of providing personalized health
information, which is often an unmet need for patients. Taken
as a whole, this is the first e-tool in the field of oncology that
aims at helping patients in their personal care management and
provides an additional overview of information about NHL.
Comparison With Prior Work
Involving patients in the development of health care
improvement tools has been an upcoming phenomenon in the
past several years. Nowadays, the patient’s voice is incorporated
more often in clinical guidelines, quality indicators, and shared
decision-making instruments [8,25,26]. It is important to support
patients involved in developing health care improvement tools.
For example, a wiki has been established for, and tested by,
patients involved in the development of a guideline on infertility
[27]. The shared decision-making instruments themselves also
have a supporting role, as they try to help patients in making
informed decisions [6,28-30]. However, not all decision aids
are directed to patients [31,32] and they usually do not provide
insight into the complete personal care pathway.
Studies focusing on personalized care pathways and assistance
with patients’personal care management are sparsely described
in the literature. Most studies concerning the development of
patient care pathways or roadmaps concentrate on the education
of physicians [33,34] or other health care professionals [10].
Ryhänen et al [35] and Dykes et al [36] developed tools to
educate patients about their care pathway. Dykes et al aimed at
providing education about the anticipated length of stay and
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treatment plan after acute myocardial infarction. Development
and evaluation of a breast cancer pathway, an Internet-based
patient education program, was described by Ryhänen et al. In
line with our e-tool, these studies focused on patient education
concerning the patient care pathway. However, these studies
did not include information tailored to the individual patient,
such as a chronological overview of the personal care pathway
or a diary. Atack et al [37] developed an online patient education
system including health-related information tailored to the
individual patient. Physicians were able to “prescribe”
information that met the patient’s need. However, this system
was not focused on the total care pathway and was only
pilot-tested in 8 patients. Our e-tool is the first that combines
the unmet needs of patients, including personalized information
about the patients’ care pathways and the possibility to create
a diary, together with an overview of all necessary NHL
information.
Limitations
Four limitations were identified with respect to this e-tool. First,
this e-tool has been developed for NHL patients, a patient
category with a more advanced age—incidence of NHL
increases with age—that might not be active on the Internet.
However, the mean age of NHL patients included in this study
was 61 years (SD 7), and a previous study on possible barriers
in NHL care also showed inclusion of patients of all ages [2].
Furthermore, health-related Internet use seems to increase over
time in Europe among people of all ages [38]. Second, the
questionnaire used to evaluate the e-tool was not validated, but
based on evaluation factors derived from the human,
organization, and technology-fit (HOT-fit) framework [39]. We
believe that the questionnaire developed included all necessary
items to extensively evaluate the e-tool.
Third, the evaluation study only assessed feasibility of the e-tool
on a small scale. Unfortunately, no information was available
about the 7 nonresponders, and a relatively high percentage of
the responders were highly educated, which could have
introduced some bias. A next step in the implementation is to
test the e-tool in daily NHL care and evaluate user experiences
on a larger scale. This might give insight into the possibilities
for making the e-tool appropriate on an international level and
it might serve as a good example for other oncologic diseases.
Finally, the e-tool is not yet certified by the HONcode. However,
all eight items of the code of conduct for medical and health
websites as described by HON were taken into account during
the development of the e-tool [40]. After testing the e-tool at a
larger scale we intend to apply for certification.
Conclusions
We have developed a personalized approach using an e-tool for
NHL patients. This tool contains a unique way to help patients
with their care management—it provides insight into the
personal care pathway and offers general information about
NHL. In this evaluation study, we report high satisfaction rates
and some improvement points for future use. We expect that
the e-tool will have a positive impact on both patient
empowerment and doctor-patient communication, since patients
are more informed in lay language about NHL and their personal
care pathway. It is suggested that better-informed patients are
able to ask more specific questions, which makes it possible to
improve the management of their personal care. Finally, this
e-tool may play an important role in dealing with NHL,
particularly the personal diary option, which has the potential
to provide psychosocial support for personal experiences in
NHL care. The usage and effects of the e-tool should be tested
and evaluated in future research, which is included as one of
the purposes of the PEARL study [22].
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